ARTICLE | Clinical News
Life Medical preclinical data
June 3, 1996 7:00 AM UTC
CHAI said that Repel outperformed Johnson & Johnson's Interceed product in preclinical studies. The study compared the performance of the two products in the presence of blood. ...